Article
A two-year prospective study assessing the performance of fetal chromosomal microarray analysis and next-generation sequencing in high-risk pregnancies.
Molecular genetics & genomic medicine - 1 Oct 2021
Ridnõi Konstantin, Muru Kai, Keernik Maria, Pajusalu Sander, Ustav Eva-Liina, Tammur Pille, Mölter-Väär Triin, Kahre Tiina, Šamarina Ustina, Asser Karin, Szirko Ferenc, Reimand Tiia, Õunap Katrin
Abstract excerpt
BACKGROUND: Introduction of cell-free fetal DNA (cff-DNA) testing in maternal blood opened possibilities to improve the performance of combined first-trimester screening (cFTS) in terms of better detection of trisomies and lowering invasive testing rate. The use of new molecular methods, such as chromosomal microarray analysis (CMA) and next-generation sequencing (NGS), has shown benefits in prenatal diagnosis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
